<![CDATA[Bob Cochran: Direct-to-Patient Was a 'Watershed Moment' for Commercial Trade]]>
In a video interview with Pharmaceutical Commerce, Cochran calls manufacturers' move to offer patients a direct option "a watershed moment." As he describes, Eli Lilly and a few other manufacturers decided their innovations justified allowing …